Asthma Drug Singulair Linked to Suicidal Behavior

March 30, 2008 04:44 PM
by findingDulcinea Staff
The FDA is looking into reports of people experiencing suicidal thoughts and behavior while taking Singulair. The probe may expand to similar drugs.

30-Second Summary

Singulair is a popular medication prescribed to help control asthma and treat some types of allergies. It has been on the market for about 10 years.

The Food and Drug Administration has announced that it is looking into reports that people taking the drug had suicidal thoughts and even acted on them at times.

The medication’s manufacturer, Merck, changed the drug’s labeling last year so that suicidal thinking was listed among the potential side effects. The company said in a statement that there were no reports of suicidal thinking or suicide during Singulair’s clinical trial, which involved more than 11,000 participants.

Bloggers have been quick to respond to the news. Reactions range from “how did someone not discover this before the drug was approved?” to concern that the reputation of Singulair and similar drugs could be ruined before all the facts are in.

Allergies and asthma affect millions of people. Singulair and medications in the same class, such Accolate and Zyflo, are among the many types of drugs available to relieve symptoms.

Headline Links: ‘FDA probes suicide risk in Merck’s Singulair’

Reactions: Merck, bloggers weigh in

Reference: Asthma, allergies, Singulair


Most Recent Beyond The Headlines